Latham.London

Tag Archives: CMA

PE Firms Must Evaluate Competition Strategy Ahead of Brexit

By Jonathan Parker and Greg Bonné As the UK Competition and Markets Authority (CMA) prepares to assume sole jurisdiction for UK competition reviews post-Brexit, private equity deal teams must evaluate the competitive consequences of deals bridging the Brexit period and update their competition strategy accordingly. What is Changing? The European Commission (EC) currently acts as a … Continue Reading

Competition Appeal Tribunal Refuses Interim Relief in Pharma Pricing Case

By Jonathan Parker, Hanna Roos, Hayley Pizzey and James Fagan The Competition Appeal Tribunal (the CAT) in the UK heard on 17 January 2017 an application by Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd (together Flynn) to suspend the Competition and Markets Authority’s (the CMA) direction to reduce the price of an epilepsy drug. … Continue Reading

UK CMA Announces Closure of Investigation into PCWs for Energy Tariffs

By John Colahan and Calum Warren On 6 October 2016, the UK Competition and Markets Authority (CMA) announced the closure of its investigation into a suspected competition law breach by some price comparison websites (PCWs) for energy tariffs on the grounds of administrative priorities. The suspected competition law breach related to certain paid online search … Continue Reading
LexBlog